Latest Breaking News On - Amarin pharmaceuticals ireland - Page 3 : comparemela.com

New REDUCE-IT® Data Show VASCEPA®/VAZKEPA® (icosapent

Data Show VASCEPA/VAZKEPA Significantly Reduced First and Total Cardiovascular Events in Combined Current and Former Smokers by 23% and 29% Respectively.

GermanyUnited statesNew jerseyUnited kingdomPhiladelphiaPennsylvaniaLebanonUniversity of pennsylvaniaUnited arab emiratesIrelandDublinCanadaSpainSwitzerlandBarcelonaComunidad autonoma de cataluna

Amarin Corporation plc: New REDUCE-IT Data Show VASCEPA/VAZKEPA (icosapent ethyl) Reduced Cardiovascular Events in Patients Who Are Current or Former Smokers

Data Show VASCEPA/VAZKEPA Significantly Reduced First and Total Cardiovascular Events in Combined Current and Former Smokers by 23% and 29% Respectively Relative to Placebo in a Post Hoc Analysis

GermanyUnited statesNew jerseyUnited kingdomPhiladelphiaPennsylvaniaLebanonUniversity of pennsylvaniaUnited arab emiratesIrelandDublinCanadaSpainSwitzerlandBarcelonaComunidad autonoma de cataluna

Investegate |Amarin Corporation plc Announcements | Amarin Corporation plc: New REDUCE-IT® Data Show VASCEPA®/VAZKEPA® (icosapent ethyl) Reduced STEMI as Well as Other MI Subtypes

Investegate announcements from Amarin Corporation plc, New REDUCE-IT® Data Show VASCEPA®/VAZKEPA® (icosapent ethyl) Reduced STEMI as Well as Other MI Subtypes

GermanyUnited statesNew jerseyUnited kingdomLebanonUnited arab emiratesIrelandCanadaDublinSpainSwitzerlandBarcelonaComunidad autonoma de catalunaScotlandGreat britainAmerican

Amarin Corporation plc: New REDUCE-IT Data Show VASCEPA/VAZKEPA (icosapent ethyl) Reduced STEMI as Well as Other MI Subtypes

Late-Breaking Data Show VASCEPA/VAZKEPA Significantly Reduced STEMI by 40% and NSTEMI by 27% in Pre-Specified, Post Hoc Analyses Data Presented During Late-Breaking Science Session at European

GermanyUnited statesNew jerseyUnited kingdomLebanonUnited arab emiratesIrelandCanadaDublinSpainSwitzerlandBarcelonaComunidad autonoma de catalunaScotlandGreat britainAmerican

Amarin Receives Positive Recommendation from United Kingdom's (UK) National Institute for Health and Care Excellence (NICE) for Reimbursement of VAZKEPA® (icosapent ethyl)

Amarin Receives Positive Recommendation from United Kingdom's (UK) National Institute for Health and Care Excellence (NICE) for Reimbursement of VAZKEPA® (icosapent ethyl)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

GermanyUnited statesNew jerseyUnited kingdomLebanonSwedenUnited arab emiratesIrelandCanadaDublinSwitzerlandNorthern irelandCraigavonScotlandGreat britainBritish